NCT04031417

Brief Summary

Diabetes is an increasingly common condition which affects millions of people in the United Kingdom. Patients with type 2 diabetes are at increased risk to develop severe heart disease and vascular complications and these can result in death. A cornerstone of the treatment is lifestyle and diet. The number of travellers is increasing quickly and there are more people than ever travelling by airplane. During a commercial flight the pressure of the air is lower than the pressure on the surface and that results in lower concentration of oxygen in the air we are breathing while flying. Also the humidity is very low inside an aircraft. The aims of this study are to show if we can use a simulated flight as a method to look at how the endothelial cells react and to see if this is different between patients with type 2 diabetes mellitus and healthy volunteers. A sub-study is also incorporated to look at different dietary interventions in type 2 diabetes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable type-2-diabetes

Timeline
Completed

Started Mar 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

July 11, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

July 24, 2019

Completed
Last Updated

August 18, 2022

Status Verified

August 1, 2022

Enrollment Period

10 months

First QC Date

July 11, 2019

Last Update Submit

August 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hypoxia and low humidity on the endothelial function in healthy volunteers and patients with type 2 diabetes using Wilcoxon signed rank test

    To determine the effect of hypoxia and low humidity on the endothelial function in healthy volunteers and patients with type 2 diabetes

    Change from Baseline to 2 hours

Study Arms (3)

Placebo

OTHER

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Other: HypoxiaOther: Low Humidity

soy isoflavones

OTHER

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Other: HypoxiaOther: Low Humidity

soy isoflavones & cocoa polyphenols

OTHER

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Other: HypoxiaOther: Low Humidity

Interventions

HypoxiaOTHER
Placebosoy isoflavonessoy isoflavones & cocoa polyphenols
Placebosoy isoflavonessoy isoflavones & cocoa polyphenols

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diabetes group:
  • Diagnosis of type 2 diabetes
  • Patients on stable medication (for their diabetes metformin being the only treatment if any), for 3 months prior to entry into the study
  • Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing hormone replacement therapy (HRT)
  • Healthy volunteers group:
  • No current disease or medication which would have effect on the safety of the subjects or interfere with the study results
  • Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing HRT

You may not qualify if:

  • For both groups:
  • Patients with concurrent illness or any medication in the last 3 months that would interfere with the study based on the investigator's judgement
  • Acute coronary syndrome in the last 3 months or any major clinical event in the previous 3 months that would effect the study based on the investigator's judgement
  • Patients not wishing to allow disclosure to their general practitioner (GP)s.
  • HbA1c \>9%
  • Smokers
  • Pre-menopausal women or post-menopausal women on HRT
  • Claustrophobia, panic attacks in the anamnesis
  • Subjects must not have been subjected to a commercial flight within 4 weeks of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Konya J, Spurgeon BEJ, Al Qaissi A, Sathyapalan T, Ajjan R, Madden L, Naseem KM, Garrett AT, Kilpatrick E, Atkin SL. The Effect of a Simulated Commercial Flight Environment with Hypoxia and Low Humidity on Clotting, Platelet, and Endothelial Function in Participants with Type 2 Diabetes - A Cross-over Study. Front Endocrinol (Lausanne). 2018 Feb 13;9:26. doi: 10.3389/fendo.2018.00026. eCollection 2018.

Related Links

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

SLH1 protein, Arabidopsis

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Sathyapalan Thozhukat, MBBS MD

    University of Hull, UK

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2019

First Posted

July 24, 2019

Study Start

March 1, 2013

Primary Completion

January 1, 2014

Study Completion

January 1, 2015

Last Updated

August 18, 2022

Record last verified: 2022-08